258 related articles for article (PubMed ID: 29986403)
1. A Novel Desloratadine-Benzoic Acid Co-Amorphous Solid: Preparation, Characterization, and Stability Evaluation.
Ainurofiq A; Mauludin R; Mudhakir D; Soewandhi SN
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 29986403
[TBL] [Abstract][Full Text] [Related]
2. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and stability study of desloratadine multicomponent crystal formation.
Ainurofiq A; Mauludin R; Mudhakir D; Soewandhi SN
Res Pharm Sci; 2018 Apr; 13(2):93-102. PubMed ID: 29606963
[TBL] [Abstract][Full Text] [Related]
4. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
5. Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors.
An JH; Lim C; Kiyonga AN; Chung IH; Lee IK; Mo K; Park M; Youn W; Choi WR; Suh YG; Jung K
Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30189645
[TBL] [Abstract][Full Text] [Related]
6. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.
Huang Y; Zhang Q; Wang JR; Lin KL; Mei X
Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301
[TBL] [Abstract][Full Text] [Related]
7. [Co-amorphous technology to improve dissolution and physical stability of silybin].
Liu H; Zhao GW; Jiang QY; Liang XL; Ouyang LQ; Ding HB; Chen XL; Liao ZG
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):103-110. PubMed ID: 35178916
[TBL] [Abstract][Full Text] [Related]
8. Tannic acid as a co-former in co-amorphous systems: Enhancing their physical stability, solubility and dissolution behavior.
Fael H; Demirel AL
Int J Pharm; 2020 May; 581():119284. PubMed ID: 32243965
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
10. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
[TBL] [Abstract][Full Text] [Related]
11. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
12. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study.
Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C
Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
Kasten G; Lobo L; Dengale S; Grohganz H; Rades T; Löbmann K
Eur J Pharm Biopharm; 2018 Nov; 132():192-199. PubMed ID: 30266670
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Characterization and Prevention of Auto-oxidation of Amorphous Sirolimus by Encapsulation in Polymeric Films Using Hot Melt Extrusion.
Kanaujia P; Poovizhi P; Ng WK; Tan RBH
Curr Drug Deliv; 2019; 16(7):663-671. PubMed ID: 31038065
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
18. Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods.
Park H; Jin Seo H; Hong SH; Ha ES; Lee S; Kim JS; Baek IH; Kim MS; Hwang SJ
Int J Pharm; 2020 May; 581():119232. PubMed ID: 32240805
[TBL] [Abstract][Full Text] [Related]
19. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
[TBL] [Abstract][Full Text] [Related]
20. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
Liu X; Zhou L; Zhang F
Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
